Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015616	s-ipro	— (—)	433	528	100.00%	Distribution not available
3015616	s-ipro	mmol/l (mmol/l)	45	50	70.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Substance abuse, excluding more controls

349

58.93

307.65

1.3

1.0

2.34

—

mmol/l

—

Alcohol abuse, main dg, excluding more controls

154

87.39

292.63

1.5

1.0

2.80

—

mmol/l

—

Mood disorders, excluding more controls

217

22.02

201.98

1.4

1.0

1.99

—

mmol/l

—

Schizophrenia or delusion, excluding more controls

101

37.25

162.01

1.4

1.1

2.06

—

mmol/l

—

Personality disorders, excluding more controls

39.46

160.77

1.7

1.0

2.51

—

mmol/l

—

Anxiety (asthma-related co-morbidities)

135

21.83

152.48

1.5

1.1

2.41

—

mmol/l

—

Anxiety disorders, excluding more controls

155

19.44

147.87

1.5

1.0

1.99

—

mmol/l

—

Implicit bacterial Sepsis

133

12.55

125.17

1.2

1.1

1.62

—

mmol/l

—

Bacterial Sepsis

135

12.20

124.26

1.2

1.1

1.62

—

mmol/l

—

Implicit bacterial Sepsis

124

12.70

119.31

1.2

1.1

1.62

—

mmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

31.62

104.45

1.9

1.3

2.34

—

mmol/l

—

Persons encountering health services in other circumstances

102

111

9.18

84.14

1.7

1.1

2.20

—

mmol/l

—

Specific personality disorders

10.66

82.81

1.7

1.2

2.55

—

mmol/l

—

Other anxiety disorders

115

126

7.94

79.36

1.5

1.1

2.10

—

mmol/l

—

Other bacterial diseases

181

242

5.04

73.36

1.2

1.3

1.52

2.88

mmol/l

—

22.40

72.14

1.1

1.0

—

mmol/l

—

All anxiety disorders

136

181

5.95

69.93

1.5

1.1

2.41

—

mmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

120

7.20

58.24

1.9

1.1

1.62

—

mmol/l

—

Pneumonitis due to solids and liquids

17.24

55.76

1.1

1.3

—

mmol/l

—

Other specified and unspecified personality disorders

16.46

52.15

1.7

1.3

3.06

—

mmol/l

—

Traumatic subdural haemorrhage

15.38

48.07

1.1

—

mmol/l

—

Lung diseases due to external agents

10.28

42.18

1.1

1.3

—

mmol/l

—

Type of accident

108

5.67

32.89

2.1

1.1

1.62

—

mmol/l

—

Dialysis, with operation codes

8.83

28.91

1.3

1.2

—

mmol/l

—

Mental and behavioural disorders due to opioids

36.78

28.43

1.2

1.8

—

Panic disorder

8.98

27.68

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

125

301

2.95

25.42

1.3

1.2

2.16

2.38

mmol/l

—

Fracture of lower leg, including ankle

242

3.32

21.97

1.2

1.3

2.26

2.14

mmol/l

—

Injuries to the wrist and hand

126

329

2.66

21.17

1.5

1.1

1.72

2.52

mmol/l

—

Hypertensive diseases (excluding secondary)

105

3.88

20.08

1.2

1.3

—

2.33

mmol/l

—

Hernia of abdominal wall, postoperative

7.32

18.63

1.1

—

Hypertension, essential

188

2.92

18.28

1.2

—

2.29

mmol/l

—

Hypothyroidism (congenital or acquired)

12.85

18.25

1.1

1.0

—

mmol/l

—

Type 2 diabetes, wide definition

200

2.92

17.77

1.1

1.2

—

1.24

mmol/l

—

Phobic anxiety disorders

7.37

17.33

1.1

1.3

—

mmol/l

—

Hypothyroidism, levothyroxine purchases

11.83

16.15

1.1

1.0

—

mmol/l

—

Hypothyroidism and >3 levothyroxin purchases

11.83

16.15

1.1

1.0

—

mmol/l

—

Nontraumatic intracranial haemmorrhage

5.10

14.54

1.0

1.2

—

mmol/l

—

Nephropathy related operations

5.32

13.70

1.4

1.2

—

mmol/l

—

Hypertensive diseases

194

2.59

13.64

1.2

—

2.29

mmol/l

—

Hypertension

194

2.59

13.64

1.2

—

2.29

mmol/l

—

Intracerebral haemorrhage

6.49

13.63

1.0

1.3

—

mmol/l

—

Psychotic depression

34.19

13.50

1.2

1.0

—

mmol/l

—

Gastroduodenal ulcer

4.09

12.66

1.3

1.2

—

mmol/l

—

Atrial fibrillation and flutter with reimbursement

5.06

12.62

1.1

1.2

—

mmol/l

—

Non-invasive ventilation

18.87

12.50

1.1

1.0

—

Traumatic subarachnoid haemorrhage

24.52

12.47

1.1

1.3

—

mmol/l

—

Hard cardiovascular diseases

225

2.41

12.34

1.2

—

1.66

mmol/l

—

Other symptoms and signs involving general sensations and perceptions

19.07

11.59

1.1

1.3

—

Explicit bacterial Sepsis

9.24

11.46

1.1

1.3

—

Complications of surgical and medical care, not elsewhere classified

102

323

2.16

11.25

1.4

1.2

2.48

1.76

mmol/l

—

Type 2 diabetes

260

2.23

11.22

1.1

1.2

—

2.05

mmol/l

—

Other maltreatment syndromes

15.64

10.84

1.1

1.7

—

Fracture of forearm

204

2.65

10.84

1.1

1.2

—

2.22

mmol/l

—

Gastric ulcer

4.72

10.69

1.3

1.2

—

Early onset COPD, excluding more controls

4.34

10.48

1.2

—

mmol/l

—

8.17

10.29

1.1

1.2

—

mmol/l

—

Unspecified kidney failure

9.13

9.99

1.3

1.2

—

mmol/l

—

Thiamine deficiency

+∞

9.44

1.1

0.0

—

mmol/l

—

Other and unspecified injuries of head

10.68

9.27

1.1

1.4

—

Type 2 diabetes, definitions combined

247

2.12

9.04

1.1

1.2

—

1.53

mmol/l

—

Type 2 diabetes, strict (exclude DM1)

250

2.09

8.79

1.1

1.2

—

1.53

mmol/l

—

Post-traumatic stress disorder

9.48

8.76

1.2

1.3

—

Dysphagia

3.94

8.58

1.1

1.2

—

mmol/l

—

Other (not insulin) diabetes medications

267

2.00

7.98

1.1

1.2

—

1.53

mmol/l

—

Injury of other and unspecified intrathoracic organs

6.96

7.76

1.3

1.4

—

mmol/l

—

Unspecified event, undetermined intent

15.16

7.72

1.1

1.6

—

mmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

252

1.99

7.50

1.1

1.2

—

1.53

mmol/l

—

Any dementia, excluding more controls

4.67

7.41

1.2

1.0

—

mmol/l

—

Toxic effect of organic solvents

+∞

7.35

3.3

0.0

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.80

7.32

1.1

1.4

—

1.66

mmol/l

—

Other degenerative diseases of the nervous system

4.27

7.26

1.5

1.1

—

mmol/l

—

Cardiac arrhythmias

135

2.41

7.10

1.1

1.5

—

1.66

mmol/l

—

Degeneration of the brain due to alcohol

13.92

6.90

1.7

1.3

—

mmol/l

—

Degeneration of nervous system due to alcohol

13.92

6.90

1.7

1.3

—

mmol/l

—

Dissociative [conversion] disorders

13.83

6.89

4.3

1.6

—

Implicit fungal Sepsis

8.27

6.82

1.1

1.4

—

Symptoms and signs involving emotional state

12.32

6.58

1.1

2.1

—

Monoamine oxidase A inhibitors

6.54

6.32

1.0

1.1

—

mmol/l

—

Status epilepticus

9.29

6.29

1.1

1.5

—

mmol/l

—

Hypertensive Heart Disease

3.58

6.20

1.0

1.1

—

Neuromuscular dysfunction of bladder

5.02

5.86

2.6

1.1

—

mmol/l

—

Injuries involving multiple body regions

8.05

5.84

1.1

1.5

—

Mental and behavioural disorders due to tobacco

5.35

5.83

1.0

1.3

—

Focal brain injury

8.02

5.83

1.0

1.1

—

mmol/l

—

Open wound of abdomen, lower back and pelvis

8.52

5.56

1.3

1.4

—

mmol/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

7.40

5.55

1.1

2.2

—

Open wound of ankle and foot

3.82

5.53

1.1

1.3

—

mmol/l

—

Early onset COPD

2.77

5.45

1.2

—

mmol/l

—

Alcoholic gastritis

16.21

5.42

2.1

1.4

—

mmol/l

—

Suppurative and necrotic conditions of lower respiratory tract

6.22

5.38

1.1

1.5

—

Folate deficiency anaemia

+∞

5.22

1.0

0.0

—

mmol/l

—

Other ill-defined and unspecified causes of mortality

5.93

5.21

1.1

—

mmol/l

—

Gout, strict definition

3.13

5.18

1.1

1.3

—

mmol/l

—

Episodal and paroxysmal disorders

291

1.70

5.15

1.6

1.2

1.82

2.43

mmol/l

—

Agoraphobia

13.40

5.08

1.0

1.8

—

Social phobias

5.67

5.05

1.2

1.3

—

mmol/l

—

Smoking dependency

4.46

5.04

1.0

1.3

—

Other mental disorders due to brain damage and dysfunction and to physical disease

4.46

5.04

1.3

1.1

—

mmol/l

—

Duodenal ulcer

4.70

4.98

1.2

1.3

—

mmol/l

—

Oesophageal varices

6.04

4.91

1.1

—

mmol/l

—

Implicit fungal Sepsis

9.05

4.78

1.1

1.7

—

Ill-defined and unknown causes of mortality

5.21

4.76

1.1

—

mmol/l

—

Cirrhosis of liver, NAS

5.74

4.75

1.0

1.1

—

mmol/l

—

Toxic liver disease

14.14

4.58

1.1

1.0

—

Cardiomyopathy

2.86

4.48

1.3

1.2

—

mmol/l

—

Symptoms and signs concerning food and fluid intake

5.22

4.44

1.0

1.3

—

Fungal Sepsis

7.54

4.35

1.1

1.6

—

Fracture of neck

5.02

4.31

1.1

1.4

—

mmol/l

—

Superficial injuries involving multiple body regions

8.94

4.28

1.1

1.9

—

Diffuse brain injury

8.93

4.28

1.1

1.2

—

mmol/l

—

Unspecified jaundice

8.92

4.28

1.0

1.6

—

mmol/l

—

Special screening examination for infectious and parasitic diseases

2.81

4.27

1.0

1.1

—

Other diseases of intestine

3.27

4.18

1.5

1.4

—

Sequelae of injuries of head

5.26

4.14

1.0

1.5

—

mmol/l

—

Fibrosis and cirrhosis of liver

4.63

4.05

1.0

1.3

—

mmol/l

—

Acute gastritis

4.63

4.05

1.0

1.4

—

Other diseases of pancreas

4.63

4.05

1.3

1.2

—

mmol/l

—

Speech disturbances, not elsewhere classified

4.20

4.01

1.1

1.3

—

mmol/l

—

Lesion of ulnar nerve

2.82

3.95

1.1

1.3

—

mmol/l

—

COPD-related respiratory insufficiency

3.79

3.88

1.0

1.2

—

Gout, idiopatic and unspecified

100

2.40

3.88

1.1

1.2

—

mmol/l

—

Early complications of trauma

5.29

3.83

1.6

1.5

—

mmol/l

—

!Aliquae complicationes praecoces traumatis

5.29

3.83

1.6

1.5

—

mmol/l

—

Vascular diseases of the intestine

8.78

3.77

1.1

1.3

—

Conduct disorder

12.06

3.76

4.8

1.0

—

Other respiratory diseases principally affecting the interstitium

2.91

3.73

1.2

—

mmol/l

—

Ischemic heart diseases

249

1.66

3.67

1.2

—

1.98

mmol/l

—

Gout, FINNGEN

115

2.26

3.67

1.2

—

mmol/l

—

Acute posthaemorrhagic anaemia

7.81

3.56

1.0

1.6

—

Hypothyroidism, drug reimbursement

7.06

3.54

1.0

—

ILD, hospital admissions

3.05

3.52

1.2

—

mmol/l

—

Other interstitial pulmonary diseases

3.05

3.52

1.2

—

mmol/l

—

Interstitial lung disease endpoints

3.05

3.52

1.2

—

mmol/l

—

Interstitial lung disease

3.05

3.52

1.2

—

mmol/l

—

Pyothorax

5.32

3.51

1.1

1.4

—

Barrett oesophagus

6.17

3.50

1.8

1.2

—

mmol/l

—

Respiratory insufficiency

5.29

3.50

1.0

1.4

—

mmol/l

—

Undetermined asthma

4.08

3.39

1.1

1.3

—

mmol/l

—

Fibroblastic disorders

2.44

3.37

1.2

—

mmol/l

—

Paralytic ileus

7.02

3.36

1.1

1.7

—

Gout, unspecified

2.47

3.29

1.1

1.2

—

mmol/l

—

Thiazolidinediones

3.64

3.28

1.0

1.2

—

Somatoform disorder

3.03

3.24

1.2

—

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

6.40

3.19

1.9

1.7

—

Idiopathic gout

3.80

3.18

1.2

1.1

—

Undetermined asthma, excluding more controls

3.80

3.18

1.1

1.4

—

mmol/l

—

Haemorrhage from respiratory passages

105

2.15

3.13

1.1

—

mmol/l

—

Lesion of lateral popliteal nerve

4.52

3.11

1.0

1.5

—

mmol/l

—

Neuralgia and neuritis, unspecified

4.51

3.11

1.3

1.4

—

Visual impairment including blindness (binocular or monocular)

4.51

3.11

1.3

1.4

—

mmol/l

—

Pneumonia derived septicemia

5.86

3.02

1.0

1.6

—

Special screening examination for other diseases and disorders

3.55

2.98

1.1

1.2

—

Moderate visual impairment, binocular

10.03

2.98

1.4

1.0

—

mmol/l

—

Peripheral arterial reconstruction

2.83

2.91

1.0

1.2

—

Hemiplegia

4.10

2.88

3.6

1.5

—

mmol/l

—

ILD, hospital admission 2, with pulmonary infections

3.71

2.87

1.3

—

Degenerative diseases of the nervous system

2.24

2.79

1.4

1.1

—

mmol/l

—

Oesophagitis

4.46

2.79

1.8

1.1

—

mmol/l

—

Other or ill-defined heart diseases

4.45

2.79

1.3

1.6

—

ILD, hospital admissions 3, with pneumonia sepsis

3.92

2.77

1.0

1.3

—

Myalgia

2.31

2.74

1.1

1.2

—

Mumps

6.03

2.70

1.0

1.5

—

Malignant neoplasm of oral cavity

6.02

2.70

1.0

1.2

—

Extreme obesity with alveolar hypoventilation

4.23

2.68

1.1

1.5

—

mmol/l

—

Burns and corrosions of multiple and unspecified body regions

7.18

2.55

1.0

—

Striking against or struck by other objects

178

1.80

2.53

1.3

1.4

—

1.82

mmol/l

—

Chronic ulcer of skin, not elsewhere classified

3.47

2.48

1.3

1.1

—

Malignant neoplasm of oral cavity, including Hilmo

4.39

2.47

1.0

1.1

—

Exposure to smoke, fire and flames

6.28

2.37

1.0

1.6

—

Volvulus

6.27

2.37

1.0

2.3

—

mmol/l

—

Complications of other internal prosthetic devices, implants and grafts

6.26

2.37

1.2

1.0

—

mmol/l

—

6.24

2.36

1.2

1.0

—

mmol/l

—

Residual foreign body in soft tissue

3.65

2.36

1.0

1.3

—

Vascular disorders of the intestines

4.12

2.36

1.1

1.4

—

Glomerular disorders in diseases classified elsewhere

2.61

2.35

1.0

1.2

—

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

112

1.91

2.35

1.2

—

mmol/l

—

Subarachnoid haemorrhage

2.95

2.28

1.0

1.3

—

Pneumococcal septicemia

4.63

2.27

1.0

1.8

—

Generalized epilepsy, strict definition

5.58

2.21

2.0

1.9

—

Schizotypal disorder

5.58

2.21

1.0

1.6

—

therapeutic use

5.57

2.21

1.0

1.8

—

Bacterial meningitis

5.57

2.21

1.0

1.9

—

Enlarged lymph nodes

2.86

2.20

1.4

1.2

—

mmol/l

—

Cardiomyopathy (excluding other)

2.50

2.18

1.0

1.4

—

mmol/l

—

Ulcer of lower limb, not elsewhere classified

2.50

2.18

1.0

1.1

—

Burns and corrosions confined to eye and internal organs

5.02

2.07

1.4

1.5

—

Diabetic nephropathy, excluding more controls

2.16

2.06

1.0

1.2

—

mmol/l

—

Artificial opening status

3.51

2.05

1.1

—

Alzheimer disease, excluding more controls

5.49

2.04

1.2

1.0

—

Myocarditis

4.01

2.04

1.2

1.3

—

Emphysema

3.08

2.01

1.0

1.3

—

mmol/l

—

Disorder of lipoprotein metabolism, unspecified

2.82

2.00

1.0

1.1

—

Undefined dementia

3.95

1.99

1.3

1.1

—

Other symptoms and signs involving the digestive system and abdomen

2.57

1.94

1.2

—

mmol/l

—

Care involving dialysis

2.97

1.93

1.0

1.3

—

Other disorders of kidney and ureter

2.39

1.85

1.2

1.3

—

mmol/l

—

Unspecified dementia

3.60

1.84

1.3

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

294

1.49

1.83

1.1

1.3

—

2.31

mmol/l

—

Injury of nerves at wrist and hand level

4.18

1.82

1.0

1.2

—

mmol/l

—

Familial hypercholesterolemia

2.57

1.80

1.1

—

mmol/l

—

Intestinal malabsorption

3.34

1.74

1.5

1.4

—

Malignant neoplasm of head and neck

2.67

1.72

1.0

1.1

—

mmol/l

—

Any dementia

1.85

1.71

1.2

1.1

—

mmol/l

—

Other sleep disorders

2.50

1.66

1.4

1.3

—

Contact with nonpowered hand tool

3.17

1.66

1.0

1.1

—

Tobacco use

2.81

1.65

1.0

1.4

—

Olecranon bursitis

2.80

1.65

1.1

1.6

—

Other arrhythmias

207

1.49

1.63

1.1

1.3

—

1.66

mmol/l

—

Nonischemic cardiomyopathy

2.50

1.59

1.0

1.3

—

mmol/l

—

Unknown and unspecified causes of morbidity

3.00

1.58

1.3

1.4

—

Arterial embolism and thrombosis

3.00

1.58

1.2

1.3

—

Other orthopaedic follow-up care

2.86

1.50

1.0

1.2

—

Dementia

1.76

1.49

1.2

1.1

—

mmol/l

—

Dilated cardiomyopathy

2.22

1.46

1.0

1.3

—

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

323

1.40

1.45

1.1

1.3

—

2.31

mmol/l

—

Cyst of kidney

2.50

1.45

1.3

1.4

—

mmol/l

—

Cluster headache, strict

3.13

1.44

5.6

1.4

—

Panniculitis affecting regions of neck and back

3.13

1.44

1.0

1.3

—

Cluster headache, wide

3.13

1.44

5.6

1.4

—

Abnormal blood-pressure reading, without diagnosis

3.13

1.44

1.0

1.3

—

Trochanteric bursitis

2.31

1.42

1.0

1.2

—

Non-allergic asthma (mode), excluding more controls

2.29

1.41

1.0

1.3

—

mmol/l

—

Dementia in Alzheimer disease

2.46

1.40

1.0

—

Other infectious diseases

2.42

1.39

1.0

1.3

—

Other diseases of stomach and duodenum

2.61

1.36

1.0

1.4

—

Other and unspecified abdominal hernia

2.95

1.36

1.0

1.6

—

Sulfonylureas

1.75

1.36

1.0

1.2

—

mmol/l

—

Benign neoplasm: Caecum

0.00

1.34

0.0

1.3

—

Cardiomyopathies, Primary/intrinsic

2.13

1.33

1.0

1.3

—

mmol/l

—

Orchitis and epididymitis

2.14

1.33

1.1

1.2

—

Major coronary heart disease event

265

1.34

1.32

1.2

—

1.98

mmol/l

—

Non-allergic asthma (mode)

2.12

1.32

1.0

1.3

—

mmol/l

—

Other disorders of penis

2.09

1.30

1.0

1.2

—

Plantar fascial fibromatosis

2.36

1.29

1.3

—

mmol/l

—

Rubella [German measles]

2.78

1.28

1.2

1.4

—

mmol/l

—

Other and unspecified injuries of ankle and foot

2.78

1.28

1.2

1.6

—

Macular hole

2.78

1.28

1.0

1.1

—

Right hemicolectomy

2.78

1.28

1.0

1.6

—

Noninfective enteritis and colitis

226

1.46

1.27

1.2

1.4

—

1.75

mmol/l

—

Colectomy operation

2.00

1.27

1.0

1.2

—

Adhesive capsulitis of shoulder

2.00

1.27

1.2

1.3

—

ILD, hospital admissions 1, main diag only

2.00

1.23

1.0

1.3

—

mmol/l

—

Contusion of other and unspecified parts of foot

2.64

1.21

1.0

1.4

—

Other arthrosis

192

1.41

1.20

1.1

1.2

—

1.94

mmol/l

—

Extracorporeal dialysis

2.31

1.18

1.0

1.4

—

Other blood glucose lowering drugs, excl. Insulins

2.00

1.16

1.1

1.4

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

328

1.29

1.15

1.1

1.2

—

1.79

mmol/l

—

Meningitis

2.50

1.15

1.0

1.4

—

Other diseases of oesophagus

2.33

1.12

1.1

1.3

—

mmol/l

—

Perforation of tympanic membrane

2.00

1.12

1.0

1.3

—

mmol/l

—

Spondylopathies

235

1.32

1.09

1.1

1.2

—

1.24

mmol/l

—

Intermittent heterotropia

2.38

1.09

1.2

1.5

—

Benign neoplasm: Cerebral meninges

2.19

1.08

1.0

1.3

—

mmol/l

—

Other infectious diseases

2.12

1.05

1.0

1.3

—

Hydronephrosis

2.27

1.03

1.0

1.1

—

Palmar fascial fibromatosis [Dupuytren]

1.83

1.02

1.2

1.3

—

mmol/l

—

1.88

1.00

1.0

1.2

—

mmol/l

—

Amiodarone users

2.00

1.00

1.1

1.3

—

Other hammer toe(s) (acquired)

1.88

0.99

1.0

1.2

—

mmol/l

—

Dementia, including avohilmo

100

1.51

0.99

1.2

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.18

0.98

1.0

1.2

—

Other secondary gonarthrosis

0.00

0.97

0.0

1.2

—

Transplanted organ and tissue status

1.89

0.94

1.0

1.2

—

Pleural effusion

1.73

0.92

1.1

1.2

—

Synovial cyst of popliteal space [Baker]

2.14

0.91

1.0

1.3

—

mmol/l

—

Fentanyl

2.14

0.91

1.2

1.3

—

Statin medication

201

1.29

0.84

1.3

1.2

—

2.45

mmol/l

—

Injury of muscle and tendon at wrist and hand level

1.76

0.83

1.0

1.2

—

Nummular dermatitis

1.88

0.81

1.0

1.2

—

mmol/l

—

Female infertility, associated with anovulation

0.00

0.78

0.0

1.0

—

Ganglion

1.62

0.78

1.1

1.6

—

Hyperparathyroidism

1.65

0.77

1.0

1.3

—

mmol/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1.84

0.73

1.0

1.3

—

Malignant neoplasm of bladder, including Hilmo

1.83

0.73

1.0

1.1

—

mmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

260

1.25

0.73

1.1

1.3

—

1.62

mmol/l

—

Need for other prophylactic measures

2.00

0.72

1.0

1.4

—

Faecal incontinence

2.00

0.72

1.0

1.2

—

Vasomotor and allergic rhinitis

180

0.65

0.72

1.0

1.2

—

Ankylosing spondylitis

1.75

0.71

1.3

—

mmol/l

—

Unspecified misadventure during surgical and medical care

1.93

0.70

5.6

1.4

—

mmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

1.85

0.68

1.0

1.4

—

Pneumothorax

1.85

0.68

1.2

1.4

—

Peripheral artery operations in Hilmo

1.67

0.68

1.0

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

291

1.22

0.67

1.1

1.3

—

1.53

mmol/l

—

conjunctival haemorrhage

1.79

0.66

2.0

1.2

—

Unspecified urinary incontinence

1.67

0.61

1.0

1.3

—

Chronic laryngitis and laryngotracheitis

1.60

0.61

1.1

—

Inflammatory disease of cervix uteri

0.00

0.60

0.0

1.3

—

Use of antiglaucoma preparations and miotics

0.00

0.60

0.0

1.5

—

Ulcerative ileocolitis

0.00

0.59

0.0

1.5

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.59

0.0

1.4

—

Colorectal cancer

0.56

0.55

1.0

1.2

—

Bronchitis, not specified as acute or chronic

1.58

0.54

1.0

1.2

—

Percutaneous Coronary Intervention

240

1.20

0.54

1.2

—

1.98

mmol/l

—

Primary coxarthrosis, bilateral

1.41

0.54

1.1

1.2

—

mmol/l

—

Coronary revascularization (ANGIO or CABG)

240

1.20

0.53

1.2

—

1.98

mmol/l

—

Myocardial infarction, with ST-elevation

1.43

0.52

1.1

1.3

—

Hypothyroidism, other/unspecified

290

1.18

0.51

1.1

1.3

—

1.53

mmol/l

—

Polyarthropathies

234

1.20

0.51

1.1

1.3

—

1.94

mmol/l

—

1.47

0.50

1.0

1.2

—

mmol/l

—

Vitreous haemorrhage

1.46

0.50

1.0

1.2

—

L04AX Other immunosuppressants

280

0.79

0.49

1.0

1.3

—

1.72

mmol/l

—

Adjustment and management of implanted device

1.49

0.47

1.1

—

mmol/l

—

Lung cancer and mesothelioma

1.43

0.46

1.3

1.2

—

mmol/l

—

Abnormal spermatozoa

1.43

0.46

1.0

1.2

—

Disorders of vitreous body and globe

201

0.76

0.45

1.0

1.2

—

1.92

—

Inflammatory diseases of prostate (prostatitis)

1.45

0.44

1.2

—

Viral pneumonia (unknown virus, not influenza)

1.61

0.43

1.0

1.3

—

Other diseases of arteries and capillaries

1.61

0.43

1.2

1.3

—

AV-block

1.43

0.42

1.0

1.2

—

mmol/l

—

Viral infections of the central nervous system

1.56

0.42

1.0

1.3

—

Amputation

1.56

0.42

1.0

1.3

—

Pacemaker

100

1.34

0.42

1.1

1.2

—

mmol/l

—

Other pleural conditions

1.52

0.41

1.0

1.3

—

Other dialysis

0.00

0.41

0.0

1.1

—

Peripheral retinal degeneration

0.00

0.41

0.0

1.7

—

Ulcerative enterocolitis

0.00

0.41

0.0

1.2

—

Meralgia paraesthetica

0.00

0.41

0.0

1.7

—

Pathological resorption of teeth

0.00

0.41

0.0

1.7

—

Other vitreous opacities

0.00

0.41

0.0

1.7

—

Malignant neoplasm of ovary, including Hilmo

0.00

0.41

0.0

1.3

—

Bicuspidal aortic valve syndrome

0.00

0.41

0.0

1.3

—

L02BX Other hormone antagonists and related agents

0.00

0.40

0.0

1.2

—

Metatarsalgia

1.47

0.40

1.0

1.3

—

Other specified and unspecified retinal disorders

0.00

0.40

0.0

1.4

—

Malignant neoplasm of pancreas

0.00

0.40

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

1.43

0.39

1.0

1.3

—

Melanocytic naevi of lower limb, including hip

0.00

0.39

0.0

1.4

—

Other noninflammatory disorders of cervix uteri

0.00

0.39

0.0

1.1

—

Cholecystitis

1.43

0.35

1.0

1.2

—

mmol/l

—

Gingivitis and periodontal diseases

295

1.12

0.34

1.3

1.2

—

1.89

mmol/l

—

Reimbursement for rheumatic diseases

264

0.83

0.34

1.1

1.3

—

1.98

mmol/l

—

ILD medications: immunosuppressive drugs

326

0.85

0.34

1.1

1.3

—

2.29

mmol/l

—

Use of anticholinesterases

0.70

0.33

1.3

1.1

—

N06DA Anticholinesterases

0.70

0.33

1.3

1.1

—

Benign neoplasm: Ascending colon

1.28

0.32

1.2

1.3

—

Other disorders of conjunctiva

1.28

0.32

1.8

1.2

—

Hallux rigidus

1.25

0.29

1.1

1.2

—

mmol/l

—

129

0.78

0.28

1.0

1.2

—

mmol/l

—

Actinic keratosis

112

0.74

0.27

1.0

1.1

—

mmol/l

—

Varicose veins

195

0.85

0.27

1.0

1.2

—

2.20

—

Caries of enamel

384

0.90

0.26

1.0

1.3

—

2.15

mmol/l

—

Diabetic neuropathy

1.21

0.26

1.0

1.2

—

Benign neoplasm: Transverse colon

1.32

0.23

1.4

1.3

—

mmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

115

0.80

0.22

1.0

1.1

—

mmol/l

—

Bruxism

0.00

0.21

0.0

1.8

—

Idiopathic urticaria

0.00

0.21

0.0

1.5

—

Other specific arthropathies, wide

0.00

0.21

0.0

1.5

—

Hypertrichosis

0.00

0.21

0.0

1.8

—

IgA nephropathy (IgA glomerulonephritis)

0.00

0.21

0.0

1.2

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.21

0.0

1.0

—

Oral leukoplakia, including avohilmo

0.00

0.21

0.0

1.2

—

Hyperaldosteronism

0.00

0.21

0.0

1.5

—

Macular cyst

0.00

0.21

0.0

1.0

—

Other and unspecified mononeuropathies of lower limb

0.00

0.21

0.0

1.5

—

Other specified/unspecified disorders of bone/cartilage

0.00

0.21

0.0

1.0

—

Rare circulating lymphoid malignancy, including Hilmo

0.00

0.21

0.0

1.2

—

Systemic lupus erythematosus, unspecified

0.00

0.21

0.0

1.7

—

Short Achilles tendon (acquired)

0.00

0.21

0.0

1.5

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.21

0.0

1.2

—

Nontoxic diffuse goitre

0.00

0.21

0.0

1.7

—

Cystic kidney disease

0.00

0.21

0.0

1.7

—

Polycythaemia vera

0.00

0.21

0.0

1.2

—

SLE, strict definition

0.00

0.21

0.0

1.7

—

SLE, ICD10

0.00

0.21

0.0

1.7

—

Cystic kidney disease

0.00

0.21

0.0

1.9

—

Systemic lupus erythematosus

0.00

0.21

0.0

1.7

—

Subacute thyroiditis

0.00

0.21

0.0

1.7

—

Multiple myeloma, including Hilmo

0.00

0.21

0.0

1.2

—

Use of selegiline

0.00

0.21

0.0

1.2

—

Keratoconus

0.00

0.21

0.0

1.4

—

Protozoal diseases

0.00

0.21

0.0

1.6

—

Use of ropinirole

0.00

0.21

0.0

1.2

—

Other benign neoplasms of uterus

0.00

0.21

0.0

1.7

—

Achilles tendinitis

1.16

0.21

1.6

1.3

—

Chondromalacia

0.00

0.21

0.0

1.6

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

0.21

0.0

1.2

—

Other acute skin changes due to ultraviolet radiation

0.00

0.21

0.0

1.4

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.6

—

Melanoma in situ

0.00

0.21

0.0

1.2

—

Malignant neoplasm of ovary

0.00

0.21

0.0

1.2

—

Respiratory tuberculosis

0.00

0.21

0.0

1.2

—

Respiratory tuberculosis, confirmed and not-confirmed

0.00

0.21

0.0

1.2

—

Tuberculosis

0.00

0.21

0.0

1.2

—

Other articular cartilage disorders

0.00

0.20

0.0

1.5

—

Erosion and ectropion of cervix uteri

0.00

0.20

0.0

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.20

0.0

1.5

—

Malignant neoplasm of mesothelium and soft tissue

0.00

0.20

0.0

1.1

—

Medial epicondylitis

0.00

0.20

0.0

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.20

0.0

1.5

—

Glaucoma-related operations

0.00

0.20

0.0

1.1

—

Female infertility, tubal origin

0.00

0.20

0.0

1.1

—

Valvular operations

1.20

0.19

1.2

1.3

—

mmol/l

—

Second line medication for Crohn's disease

290

0.90

0.18

1.0

1.3

—

1.67

mmol/l

—

Thoracic aortic aneurysm

1.21

0.18

1.0

1.3

—

mmol/l

—

Endometriosis of ovary

1.20

0.18

1.4

1.1

—

mmol/l

—

Disorders of breast

142

1.15

0.17

1.2

1.4

—

1.92

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.71

0.16

1.0

1.2

—

Disorders of sclera, cornea, iris and ciliary body

273

1.10

0.16

1.5

1.3

—

1.76

mmol/l

—

Emergency coronary revascularization (for ACS)

277

1.08

0.16

1.2

—

1.98

mmol/l

—

Alzheimer disease, including avohilmo

0.78

0.14

1.1

—

Nasal polyp

0.78

0.14

1.0

1.2

—

mmol/l

—

Parkinson's disease, including avohilmo

1.09

0.09

1.2

—

mmol/l

—

Early lumbar disc prolapse, operated

1.06

0.09

1.2

1.3

—

mmol/l

—

Lateral epicondylitis

1.07

0.08

1.2

1.3

—

Benign neoplasm: Rectum

1.04

0.08

1.1

1.2

—

Benign neoplasm: Sigmoid colon

0.82

0.07

1.2

1.3

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.07

0.07

1.3

1.1

—

mmol/l

—

Benign neoplasm: Rectum, anus and anal canal

1.08

0.07

1.3

1.2

—

Disorders of the thyroid gland

315

1.03

0.05

1.1

1.3

—

1.59

mmol/l

—

Arthrosis

222

1.04

0.05

1.2

—

1.94

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

316

1.03

0.04

1.0

1.3

—

1.79

mmol/l

—

Other enthesopathies

119

0.92

0.03

1.1

1.2

—

Haemorrhoids and perianal venous thrombosis

113

1.06

0.01

1.1

1.2

—

mmol/l

—

Unspecific neurodegenerative disorder

0.96

0.00

1.2

1.0

—

Other disorders of iris and ciliary body

0.00

0.0

1.0

—

Other protozoal intestinal diseases

0.00

0.0

1.6

—

Respiratory tuberculosis, not confirmed

0.00

0.0

1.3

—

Other abnormal immunological findings in serum

0.00

0.0

1.5

—

Third [oculomotor] nerve palsy

0.00

0.0

2.0

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

2.0

—

Other specified/unspecified spondylopathies

0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung

1.02

0.00

1.3

1.0

—

mmol/l

—

Exposure to other and unspecified man-made environmental factors

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

0.00

0.0

1.4

—

Cardiomyopathy, Hypertrophic obstructive

0.00

0.0

1.2

—

Iliotibial band syndrome

0.00

0.0

2.0

—

Problems related to social environment

0.00

0.0

2.1

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.7

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

Drug-induced osteoporosis

0.00

0.0

2.0

—

Thyroiditis, unspecified

0.00

0.0

2.3

—

Use of teriflunomide

0.00

0.0

1.6

—

Disorders of tooth development and eruption

0.99

0.00

1.0

1.1

—

mmol/l

—

Congenital malformations of breast

0.00

0.0

1.5

—

Normal-pressure hydrocephalus

0.00

0.0

1.3

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

-0.00

0.0

1.3

—

Other immunodeficiencies

0.00

-0.00

0.0

1.0

—

Hirsutism in women

0.00

-0.00

0.0

1.9

—

Diseases of spleen

0.00

-0.00

0.0

1.0

—

Other retinal artery occlusion

0.00

-0.00

0.0

1.0

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

-0.00

0.0

1.9

—

Hodgkin lymphoma, hilmo

0.00

-0.00

0.0

1.6

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

Retinoschisis and retinal cysts

0.00

-0.00

0.0

1.3

—

Dissection of aorta

0.00

-0.00

0.0

1.2

—

Other specified/unspecified deforming dorsopathies

0.00

-0.00

0.0

1.7

—

Disorders of globe

0.00

-0.00

0.0

1.3

—

Background retinopathy and retinal vascular changes

0.00

-0.00

0.0

1.8

—

Premenstrual syndrome

0.00

-0.00

0.0

1.0

—

Fistulae involving female genital tract

0.00

-0.00

0.0

1.0

—

Other assisted single delivery

0.00

-0.00

0.0

1.9

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

-0.00

0.0

2.0

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

-0.00

0.0

1.5

—

Non-small cell lung cancer, squamous

0.00

-0.00

0.0

1.3

—

Pleural plaque without asbestos

0.00

-0.00

0.0

1.3

—

Polycystic kidney disease

0.00

-0.00

0.0

1.9

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.92

-0.00

1.3

1.1

—

mmol/l

—

Arthropathy in ulcerative colitis

0.00

-0.00

0.0

1.5

—

Serous carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Primary biliary cholangitis (PBC)

0.00

-0.00

0.0

1.6

—

Postpartum care and examination

0.97

-0.00

1.3

1.5

—

Clubfoot

0.00

-0.00

0.0

1.0

—

Family history of other conditions

0.00

-0.00

0.0

1.0

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

-0.00

0.0

1.0

—

Contact with other hot metals

0.00

-0.00

0.0

1.4

—

Brain glioblastoma

0.00

-0.00

0.0

1.4

—

Graves ophthalmopathy

0.00

-0.00

0.0

1.6

—

Injury of muscle and tendon at lower leg level

0.87

-0.00

1.0

1.2

—

Crushing injury of wrist and hand

0.00

-0.00

0.0

1.4

—

Aortic aneurysm

0.96

-0.00

1.0

1.2

—

mmol/l

—

Infliximab

0.00

-0.00

0.0

1.5

—

Use of rasagiline

0.00

-0.00

0.0

1.4

—

Use of levodopa decarbox-comt-inhibitor

0.00

-0.00

0.0

1.3

—

Hydatidiform mole

0.00

-0.00

0.0

2.6

—

Placental disorders

0.00

-0.00

0.0

1.6

—

Endometriosis of fallopian tube

0.00

-0.00

0.0

1.0

—

Habitual aborter

0.00

-0.00

0.0

1.0

—

Inflammatory disorders of male genital organs, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Use of fingolimod

0.00

-0.00

0.0

1.6

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Complications associated with artificial fertilization

0.00

-0.00

0.0

1.0

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.3

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Other and unspecified nail disorders

0.00

-0.00

0.0

1.7

—

Other melanin hyperpigmentation

0.00

-0.00

0.0

1.0

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.8

—

Other and unspecified acne

0.00

-0.00

0.0

1.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

-0.00

0.0

2.1

—

Cytomegalovirus infection, IBD co-morbidity

0.00

-0.00

0.0

1.6

—

Urethritis and urethral syndrome

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

-0.00

0.0

1.2

—

Chronic Coagulation defects

0.00

-0.00

0.0

1.9

—

Other lesions of median nerve

0.00

-0.00

0.0

1.7

—

Other acute disseminated demyelination

0.00

-0.00

0.0

1.6

—

Epiphora

0.00

-0.00

0.0

1.4

—

Alzheimer disease

0.88

-0.00

1.2

1.1

—

Sexual dysfunction

0.00

-0.00

0.0

1.0

—

Graves ophthalmopathy, strict

0.00

-0.00

0.0

1.8

—

Panhypopituitarism

0.00

-0.00

0.0

1.0

—

Autoimmune thyroiditis

0.00

-0.00

0.0

1.4

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

2.3

—

Myeloid leukaemia

0.00

-0.00

0.0

1.3

—

Carcinoma in situ of other and unspecified genital organs

0.00

-0.00

0.0

2.0

—

Hereditary retinal dystrophy

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of scalp and neck

0.00

-0.00

0.0

2.3

—

CR(E)ST syndrome

0.00

-0.00

0.0

2.0

—

Benign neoplasm: Anus and anal canal

0.00

-0.00

0.0

1.0

—

Adenocarcinoma of pancreas

0.00

-0.00

0.0

1.4

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.6

—

Certain zoonotic bacterial diseases

0.00

-0.00

0.0

1.8

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.92

-0.00

1.0

1.1

—

Other overlap syndromes

0.00

-0.00

0.0

1.6

—

Non-Hodgkin lymphoma, all

0.00

-0.00

0.0

1.3

—

Use of memantine

0.92

-0.00

1.0

1.1

—

Migraine without aura, drug-induced

0.00

-0.00

0.0

1.6

—

Venous complications and haemorrhoids in pregnancy

0.00

-0.00

0.0

1.9

—

Endometriosis of intestine

0.00

-0.00

0.0

1.0

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

0.00

-0.00

0.0

2.3

—

Other disorders of breast and lactation associated with childbirth

0.00

-0.00

0.0

1.4

—

Benign neoplasm: Lip

0.00

-0.00

0.0

1.8

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

-0.00

0.0

2.0

—

Tularaemia

0.00

-0.00

0.0

1.4

—

Cytomegaloviral disease

0.00

-0.00

0.0

1.6

—

Other/unspecified cytomegaloviral diseases

0.00

-0.00

0.0

1.7

—

Pterygium

0.00

-0.00

0.0

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Isopropanol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS